PT3 is a selective inhibitor of HDAC3 with an IC50 value of 0.25 µM. PT3 exhibits good brain penetration ability and bioavailability upon oral administration. PT3 can be used in the research of Alzheimers disease[1].
Molecular Weight:
319.36
Purity:
99.94
CAS Number:
[2710273-81-5]
Formula:
C18H17N5O
Target:
HDAC
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
